Gainers
- Acorda Therapeutics ACOR stock moved upwards by 56.69% to $5.97 during Friday's pre-market session. The market value of their outstanding shares is at $66.4 million.
- NRX Pharmaceuticals NRXP shares rose 48.81% to $24.48. The market value of their outstanding shares is at $1.1 billion.
- Medigus MDGS shares increased by 23.17% to $1.86. The market value of their outstanding shares is at $44.2 million.
- Cyclerion Therapeutics CYCN shares rose 18.05% to $4.25. The market value of their outstanding shares is at $171.7 million.
- Xenetic Biosciences XBIO stock rose 15.64% to $2.15. The company's market cap stands at $18.8 million.
- NeuroMetrix NURO shares moved upwards by 8.97% to $26.95. The market value of their outstanding shares is at $133.2 million. As per the news, the Q2 earnings report came out yesterday.
Losers
- AzurRx BioPharma AZRX stock decreased by 23.94% to $0.54 during Friday's pre-market session. The company's market cap stands at $42.3 million.
- Adverum Biotechnologies ADVM shares declined by 19.61% to $2.46. The market value of their outstanding shares is at $240.9 million.
- Applied DNA Sciences APDN stock decreased by 10.5% to $5.8. The company's market cap stands at $43.4 million.
- Chembio Diagnostics CEMI shares decreased by 8.36% to $3.95. The company's market cap stands at $79.9 million.
- Sonnet BioTherapeutics SONN shares fell 6.96% to $1.07. The company's market cap stands at $22.8 million.
- ChromaDex CDXC stock fell 6.63% to $9.72. The company's market cap stands at $660.3 million.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in